CRIS Q2 2025 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$15M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+8.0% YoY

Gross Profit

$3M99.4% margin

Operating Income

-$8M-300.1% margin

Net Income

-$9M-312.6% margin

EPS (Diluted)

$-0.68

QoQ Revenue Growth

+15.5%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$29M

Total Liabilities

$43M

Stockholders' Equity

-$14M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	+8.0%
Gross Profit	$3M	$3M	+7.9%
Operating Income	-$8M	-$13M	+34.1%
Net Income	-$9M	-$12M	+27.2%

Revenue Segments

Reportable Segment

$3M100%